Evaluating potential plasma biomarkers in dementia : amyloid-β, neurofilament light chain and tau

Takeaway

  • Amyloid-β42 and neurofilament light chain (NfL) are promising plasma biomarkers for the diagnosis of early-stage Alzheimer’s disease (AD).

Why this matters ?

    Evaluating AD-related protein biomarkers in plasma could offer a faster and less invasive diagnostic approach for AD than measuring biomarkers in cerebrospinal fluid.